🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study includes 3 parts: Parts A, B, and C. The purpose of this study i...
Status
Completed
Location
Pinnacle Research Group
Start Date
2023-04-17
Trial ID
NCT05827978
Treatments Being Tested
The purpose of this clinical trial is to see if combining a licensed COVID-...
Status
Completed
Location
Orange County Research Center
Start Date
2024-01-31
Trial ID
NCT06237049
Treatments Being Tested
This is a Phase 1, single-site, open-label, comparator-controlled dose esca...
Status
Completed
Location
Duke Vaccine and Trials Unit
Start Date
2023-04-05
Trial ID
NCT05755620
This study will evaluate the reactogenicity, safety, and immune response of...
Status
Completed
Location
GSK Investigational Site
Start Date
2024-11-11
Trial ID
NCT06680375
This study is to set up a flexible trial platform using two existing nation...
Status
Completed
Location
University Hospital Basel
Start Date
2021-04-19
Trial ID
NCT04805125
The purpose of this study is to evaluate safety, tolerability and immunogen...
Status
Completed
Location
Velocity Clinical Research, Denver
Start Date
2025-08-05
Trial ID
NCT07117487
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of mRNA-10...
Status
Completed
Location
North Alabama Research Center, LLC
Start Date
2022-09-14
Trial ID
NCT05566639
Treatments Being Tested
The purpose of the study is to evaluate the immunogenicity, reactogenicity,...
Status
Completed
Location
Public Health Association.Inc.
Start Date
2024-11-18
Trial ID
NCT06694389
Treatments Being Tested
The primary objective of this clinical study is to assess the safety, and r...
Status
Completed
Location
University Hospital Ghent
Start Date
2018-10-12
Trial ID
NCT03713086
Treatments Being Tested
This is a Phase 1, single-site, comparator-controlled, dosage-escalating st...
Status
Completed
Location
University of Iowa - Infectious Disease Clinic
Start Date
2023-10-16
Trial ID
NCT05945485